Precigen

Develops precision gene and cell therapies for intractable diseases.

BiotechnologyPharmaceuticals precigen.com ↗

Company facts

Founded
1998
Employees
145
Headquarters
United States
Type
Public
Listed
NASDAQ: PGEN
Subsidiaries
PGEN Therapeutics, Precigen ActoBio, Precigen Exemplar